임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

22건 표시

2상완료· Knee Osteoarthritis
Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
리드: 종근당
상세 →NCT06954766
2상모집 중· Ovarian Cancer
Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
협력: 종근당
상세 →NCT05704621
2상완료· Androgenetic Alopecia
A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
리드: 종근당
상세 →NCT05677438
2상완료· COVID-19
A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
리드: 종근당
상세 →NCT04628143
2상완료· COVID-19
A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
리드: 종근당
상세 →NCT04623021
2상상태 미확인· Primary Open Angle Glaucoma
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
리드: 종근당
상세 →NCT04448223
2상완료· Rheumatoid Arthritis
A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate
리드: 종근당
상세 →NCT04204603
2상상태 미확인· Leiomyosarcoma Metastatic
Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment
협력: 종근당
상세 →NCT03536780
2상완료· Respiratory Infection
The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497
리드: 종근당
상세 →NCT03726853
2상상태 미확인· Urothelial Carcinoma
The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
협력: 종근당
상세 →NCT03062059
2상완료· Gastritis
Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet
리드: 종근당
상세 →NCT03437785
2상상태 미확인· EGFR Positive Non-small Cell Lung Cancer
Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients
협력: 종근당
상세 →NCT03382795
2상상태 미확인· Glaucoma, Primary Open Angle
Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
리드: 종근당
상세 →NCT03067415
2상완료· Dyslipidemias
To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
리드: 종근당
상세 →NCT02977065
2상상태 미확인· Essential Hypertension
A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
리드: 종근당
상세 →NCT02206165
2상상태 미확인· Rheumatoid Arthritis
Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)
리드: 종근당
상세 →NCT02005757
2상완료· Epithelial Ovarian Cancer
Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
리드: 종근당
상세 →NCT01630018
2상완료· Non-Small Cell Lung Cancer
BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC
협력: 종근당
상세 →NCT01243775
2상완료· Small Cell Lung Cancer
A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
리드: 종근당
상세 →NCT01497873
2상완료· Hypertension
CKD-828 Primary Hypertension Trial(Dose-selection)
리드: 종근당
상세 →NCT01128322
2상완료· Carcinoma, Non-Small-Cell Lung
Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy
리드: 종근당
상세 →NCT01022671
2상완료· Diabetes Mellitus, Type 2
Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus
리드: 종근당
상세 →NCT01030679

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.